Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 205,614,896 papers from all fields of science
Search
Sign In
Create Free Account
everolimus 5 MG Oral Tablet [Afinitor]
Known as:
Afinitor 5 MG Oral Tablet
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
8 relations
Butylated Hydroxytoluene
Crospovidone
Lactose Monohydrate
Magnesium stearate
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Evaluation of kinase-inhibitors nilotinib and everolimus against alveolar echinococcosis in vitro and in a mouse model.
D. Joekel
,
B. Lundström-Stadelmann
,
B. Müllhaupt
,
A. Hemphill
,
P. Deplazes
Experimental parasitology
2018
Corpus ID: 4931010
2015
2015
Everolimus in Metastatic Breast Cancer: Clinical Experience as a Late Treatment Line
M. Pouget
,
C. Abrial
,
+11 authors
M. Mouret-Reynier
Oncology
2015
Corpus ID: 20857498
Background: Everolimus (Afinitor®) plus exemestane are indicated for hormone receptor-positive, HER2/neu-negative metastatic…
Expand
2014
2014
Breast Cancer Treatment with Afinitor® (Everolimus) and Exemestane for ER+ Women – Ergebnisse der ersten Interimsanalyse der nicht-interventionellen Studie BRAWO
E. Grischke
,
D. Lüftner
,
+10 authors
P. Fasching
2014
Corpus ID: 75775808
2013
2013
BRAWO - Breast Cancer Treatment with Afinitor® (Everolimus) and Exemestane for ER+ Women
D. Lüftner
,
H. Tesch
,
+4 authors
C. Jackisch
2013
Corpus ID: 75649858
Review
2012
Review
2012
Pancreatic Neuroendocrine and Carcinoid Tumors: What’s New, What’s Old, and What’s Different?
D. Reidy-Lagunes
,
R. Thornton
Current Oncology Reports
2012
Corpus ID: 1106454
Well-differentiated neuroendocrine tumors (NETs) can be subdivided into carcinoid and pancreatic NETs (panNETs). Recently, two…
Expand
Review
2011
Review
2011
Everolimus for the treatment of advanced renal cell carcinoma
R. Amato
Expert opinion on pharmacotherapy
2011
Corpus ID: 19475319
Introduction: The efficacy of sequential everolimus (RAD001, Afinitor®), an orally administered inhibitor of mammalian target of…
Expand
2011
2011
1167 POSTER Comparison of the Impact of the Targeted Therapy Everolimus (Afinitor®) and the Chemotherapy 5-FU on Cognitive Functions and Cerebral Plasticity in an Animal Model
M. Dubois
,
V. Lejoncour
,
+6 authors
H. Castel
2011
Corpus ID: 71214301
Review
2009
Review
2009
Aktuelles zur Systemtherapie des metastasierten Nierenzellkarzinoms
A. Merseburger
,
S. Waalkes
,
M. Kuczyk
Der Urologe
2009
Corpus ID: 13405642
ZusammenfassungDie letzten 5 Jahre waren durch grundlegende Veränderungen in der Systemtherapie des metastasierten…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE